{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:36:31Z","timestamp":1792899391708,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022\\u202F M721060"],"award-info":[{"award-number":["2022\\u202F M721060"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304286"],"award-info":[{"award-number":["82304286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bioorg.2024.107652","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T14:58:43Z","timestamp":1721055523000},"page":"107652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Targeting DNA methyltransferases for cancer therapy"],"prefix":"10.1016","volume":"151","author":[{"given":"Kaiyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangxu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasa","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107652_b0005","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3390\/cancers12082123","article-title":"DNA methyltransferases in cancer: biology, paradox, aberrations, and targeted therapy","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2024.107652_b0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd1930","article-title":"Epigenetic therapy of cancer: past, present and future","volume":"5","author":"Yoo","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107652_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/ph14010017","article-title":"Expanding the structural diversity of DNA methyltransferase inhibitors","volume":"14","author":"Ju\u00e1rez-Mercado","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2024.107652_b0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4161\/cbt.9.4.10750","article-title":"Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors","volume":"9","author":"Li","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bioorg.2024.107652_b0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pbj.2016.10.005","article-title":"Genetic polymorphism in DNMTs and gastric cancer: a systematic review and meta-analysis","volume":"1","author":"Neves","year":"2016","journal-title":"Porto Biomed J"},{"key":"10.1016\/j.bioorg.2024.107652_b0030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/15592294.2019.1588684","article-title":"Integrative analysis identifies DNMTs against immune-infiltrating neutrophils and dendritic cells in colorectal cancer","volume":"14","author":"Shi","year":"2019","journal-title":"Epigenetics"},{"key":"10.1016\/j.bioorg.2024.107652_b0035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1039\/D3AN01915B","article-title":"A review on recent advances in assays for DNMT1: a promising diagnostic biomarker for multiple human cancers","volume":"149","author":"Yu","year":"2024","journal-title":"Analyst"},{"key":"10.1016\/j.bioorg.2024.107652_b0040","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/carcin\/bgq221","article-title":"Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors","volume":"32","author":"Chik","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bioorg.2024.107652_b0045","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1038\/cddis.2014.380","article-title":"Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3A-dependent DNA methylation","volume":"5","author":"Yan","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2024.107652_b0050","doi-asserted-by":"crossref","first-page":"e1003146","DOI":"10.1371\/journal.pgen.1003146","article-title":"DNMT3A protects active chromosome domains against cancer-associated hypomethylation","volume":"8","author":"Ren","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bioorg.2024.107652_b0055","doi-asserted-by":"crossref","first-page":"23668","DOI":"10.18632\/aging.103820","article-title":"DNMT3B silencing suppresses migration and invasion by epigenetically promoting mir-34a in bladder cancer","volume":"12","author":"Xu","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.bioorg.2024.107652_b0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/10428194.2019.1666377","article-title":"Methyltransferase DNMT3B in leukemia","volume":"61","author":"Zhang","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bioorg.2024.107652_b0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00277-005-0012-1","article-title":"An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2\u2032-deoxycytidine (decitabine) in 177 patients","volume":"84","author":"Wijermans","year":"2005","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bioorg.2024.107652_b0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.foodhyd.2016.10.029","article-title":"Resveratrol encapsulation in core-shell biopolymer nanoparticles: impact on antioxidant and anticancer activities","volume":"64","author":"Huang","year":"2017","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.bioorg.2024.107652_b0075","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.semcancer.2020.10.010","article-title":"Chemotherapeutic efficacy of curcumin and resveratrol against cancer: chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics","volume":"73","author":"Patra","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2024.107652_b0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/07357907.2012.675381","article-title":"MG98, a second-generation DNMT1 inhibitor, in the treatment of advanced renal cancer investig","volume":"30","author":"Amato","year":"2012","journal-title":"Cancer Investig"},{"key":"10.1016\/j.bioorg.2024.107652_b0085","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2174\/1386207321666171218115850","article-title":"Epigallocatechin-3-gallate (EGCG): mechanisms and the combined applications","volume":"20","author":"Song","year":"2018","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.bioorg.2024.107652_b0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-biochem-103019-102815","article-title":"Role of mammalian DNA methyltransferases in development","volume":"89","author":"Chen","year":"2020","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.bioorg.2024.107652_b0095","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bmcl.2019.01.022","article-title":"Synthesis of NSC 106084 and NSC 14778 and evaluation of their DNMT inhibitory activity","volume":"29","author":"Leroy","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107652_b0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrg.2017.80","article-title":"The DNA methyltransferase family: a versatile toolkit for epigenetic regulation","volume":"19","author":"Lyko","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bioorg.2024.107652_b0105","doi-asserted-by":"crossref","first-page":"e1009570","DOI":"10.1371\/journal.pgen.1009570","article-title":"The DNMT3A PWWP domain is essential for the normal DNA methylation landscape in mouse somatic cells and oocytes","volume":"17","author":"Bartolomei","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bioorg.2024.107652_b0110","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3390\/genes11111336","article-title":"DNMTs and impact of CpG content, transcription factors, consensus motifs, lncRNAs, and histone marks on DNA methylation","volume":"11","author":"Loaeza-Loaeza","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.bioorg.2024.107652_b0115","doi-asserted-by":"crossref","DOI":"10.1177\/1177271919846454","article-title":"Oncogenic roles and inhibitors of DNMT1, DNMT3A, and DNMT3B in acute myeloid leukaemia","volume":"14","author":"Wong","year":"2019","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.bioorg.2024.107652_b0120","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1007\/s12035-021-02298-w","article-title":"DNA methyltransferase 1 is dysregulated in parkinson\u2019s disease via mediation of miR-17","volume":"58","author":"Zhang","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2024.107652_b0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13148-018-0450-y","article-title":"Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma","volume":"10","author":"Hervouet","year":"2018","journal-title":"Clin. Epigenet"},{"key":"10.1016\/j.bioorg.2024.107652_b0130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm4043","article-title":"DNA methylation pathways and their crosstalk with histone methylation","volume":"16","author":"Du","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2024.107652_b0135","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1039\/C9CP02024A","article-title":"Insight into the selective binding mechanism of DNMT1 and DNMT3A inhibitors: a molecular simulation study","volume":"21","author":"Xie","year":"2019","journal-title":"PCCP"},{"key":"10.1016\/j.bioorg.2024.107652_b0140","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1038\/s41467-021-22665-4","article-title":"DNMT1 reads heterochromatic H4K20me3 to reinforce LINE-1 DNA methylation","volume":"12","author":"Ren","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2024.107652_b0145","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.2174\/092986710793205372","article-title":"Molecular and enzymatic profiles of mammalian DNA methyltransferases: structures and targets for drugs","volume":"17","author":"Xu","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0150","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.3390\/ijms23168994","article-title":"DNA methyltransferases: from evolution to clinical applications","volume":"23","author":"Del Castillo Falconi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107652_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-017-0081-z","article-title":"DNA methyltransferases and their roles in tumorigenesis","volume":"5","author":"Zhang","year":"2017","journal-title":"Biomark Res"},{"key":"10.1016\/j.bioorg.2024.107652_b0160","first-page":"1","article-title":"Garcia","volume":"3","author":"Godley","year":"2010","journal-title":"Jain, an Update on the Safety and Efficacy of Decitabine in the Treatment of Myelodysplastic Syndromes, OncoTargets Ther"},{"key":"10.1016\/j.bioorg.2024.107652_b0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41181-018-0041-4","article-title":"19th European symposium on radiopharmacy and radiopharmaceuticals (ESRR\u201918)","volume":"3","author":"Ait-Mohand","year":"2018","journal-title":"EJNMMI Radiopharm. Chem"},{"key":"10.1016\/j.bioorg.2024.107652_b0170","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.biochi.2012.07.025","article-title":"DNA methylation inhibitors in cancer: recent and future approaches","volume":"94","author":"Gros","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.bioorg.2024.107652_b0175","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2174\/092986708784567653","article-title":"Anticancer drug discovery targeting DNA hypermethylation","volume":"15","author":"Yu","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0180","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/nrd1726","article-title":"Azacitidine","volume":"4","author":"Issa","year":"2005","journal-title":"Nat. Rev. Drug. Disc"},{"key":"10.1016\/j.bioorg.2024.107652_b0185","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrd2180","article-title":"Decitabine","volume":"5","author":"Gore","year":"2006","journal-title":"Nat. Rev. Drug. Disc"},{"key":"10.1016\/j.bioorg.2024.107652_b0190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.leukres.2016.04.003","article-title":"Azacitidine versus decitabine in patients with refractory anemia with excess blast\u2014results of multicenter study","volume":"45","author":"Salim","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bioorg.2024.107652_b0195","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.3390\/cancers13225677","article-title":"Use of azacitidine or decitabine for the up-front setting in acute myeloid leukaemia: a systematic review and meta-analysis","volume":"13","author":"Saiz-Rodr\u00edguez","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2024.107652_b0200","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/cancers14061530","article-title":"The contrasting delayed effects of transient exposure of colorectal cancer cells to decitabine or azacitidine","volume":"14","author":"Pawlak","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2024.107652_b0205","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1021\/acscatal.6b03381","article-title":"Molecular mechanism of inhibition of DNA methylation by zebularine","volume":"7","author":"Aranda","year":"2017","journal-title":"ACS Catal."},{"key":"10.1016\/j.bioorg.2024.107652_b0210","article-title":"DNA methyltransferase and its clinical applications","volume":"512","author":"Jun","year":"2020","journal-title":"IOP Conf. Ser. Earth Environ. Sci"},{"key":"10.1016\/j.bioorg.2024.107652_b0215","doi-asserted-by":"crossref","first-page":"1072651","DOI":"10.3389\/fphar.2022.1072651","article-title":"Recent progress in DNA methyltransferase inhibitors as anticancer agents","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107652_b0220","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S0959-8049(16)32864-7","article-title":"Phase I trial of oral 5-fluoro-2\u2032-deoxycytidine with oral tetrahydrouridine in patients with advanced solid tumors","volume":"69","author":"O'Sullivan Coyne","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bioorg.2024.107652_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.12.004","article-title":"DNA methyltransferase inhibitors in cancer: from pharmacology to translational studies","volume":"129","author":"Pechalrieu","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107652_b0230","doi-asserted-by":"crossref","first-page":"vi133","DOI":"10.1093\/annonc\/mdw368.54","article-title":"First-in-human trial of 4'-thio-2'-deoxycytidine (TdCyd) in patients with advanced solid tumors","volume":"27","author":"O'Sullivan Coyne","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioorg.2024.107652_b0235","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1158\/1535-7163.MCT-09-1202","article-title":"Delivery of 5-azacytidine to human cancer cells by elaidic acid esterification increases therapeutic drug efficacy","volume":"9","author":"Brueckner","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2024.107652_b0240","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1158\/1535-7163.MCT-09-1048","article-title":"S110, a 5-aza-2\u2032-deoxycytidine\u2013containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth","volume":"9","author":"Chuang","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2024.107652_b0245","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/15592294.2016.1214781","article-title":"Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma","volume":"11","author":"Jueliger","year":"2016","journal-title":"Epigenetics"},{"key":"10.1016\/j.bioorg.2024.107652_b0250","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hep.30091","article-title":"Integrative epigenetic analysis reveals therapeutic targets to the DNA methyltransferase inhibitor guadecitabine (SGI-110) in hepatocellular carcinoma","volume":"68","author":"Liu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bioorg.2024.107652_b0255","doi-asserted-by":"crossref","first-page":"40749","DOI":"10.1074\/jbc.M505593200","article-title":"Procainamide is a specific inhibitor of DNA methyltransferase 1","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0260","article-title":"Design, synthesis and investigation of procaine based new Pd complexes as DNA methyltransferase inhibitor on gastric cancer cells","volume":"132","author":"Salih","year":"2021","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.bioorg.2024.107652_b0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/cbic.201100522","article-title":"Rapid synthesis of new DNMT inhibitors derivatives of procainamide","volume":"13","author":"Halby","year":"2012","journal-title":"Chembiochem"},{"key":"10.1016\/j.bioorg.2024.107652_b0270","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1517\/13543776.2012.729579","article-title":"DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies","volume":"22","author":"Fahy","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2024.107652_b0275","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1158\/0008-5472.CAN-04-2957","article-title":"Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases","volume":"65","author":"Brueckner","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2024.107652_b0280","first-page":"1465","article-title":"Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors, Future","volume":"9","author":"Rondelet","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0285","article-title":"Development of a kind of RG108-fluorescein conjugates for detection of DNA methyltransferase 1 (DNMT1) in living cells","volume":"607","author":"Ruan","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0290","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/cmdc.201300420","article-title":"Design, synthesis and biological evaluation of 4-amino-N-(4-aminophenyl)benzamide analogues of quinoline-based SGI-1027 as inhibitors of DNA methylation","volume":"9","author":"Rilova","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107652_b0295","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1074\/jbc.M114.594671","article-title":"New Insights on the mechanism of quinoline-based DNA methyltransferase inhibitors","volume":"290","author":"Gros","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0300","doi-asserted-by":"crossref","first-page":"9028","DOI":"10.1021\/jm501134e","article-title":"Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening","volume":"57","author":"Chen","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0305","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1080\/14756366.2022.2079640","article-title":"Design, synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties","volume":"37","author":"Li","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0310","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2174\/1389450121666200504080112","article-title":"The epigenetic modification of epigallocatechin gallate (EGCG) on cancer","volume":"21","author":"Yang","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bioorg.2024.107652_b0315","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/dmd.31.4.452","article-title":"Glucuronides of tea catechins: enzymology of biosynthesis and biological activities","volume":"31","author":"Lu","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bioorg.2024.107652_b0320","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fphar.2020.00992","article-title":"Natural products impacting DNA methyltransferases and histone deacetylases","volume":"11","author":"Akone","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107652_b0325","doi-asserted-by":"crossref","first-page":"12023","DOI":"10.3390\/ijms140612023","article-title":"Combination of low concentration of (\u2212)-epigallocatechin gallate (EGCG) and curcumin strongly suppresses the growth of non-small cell lung cancer in vitro and in vivo through causing cell cycle arrest","volume":"14","author":"Zhou","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107652_b0330","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1038\/s41598-017-09764-3","article-title":"Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ER\u03b1 expression","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107652_b0335","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3892\/or.2015.3802","article-title":"(\u2212)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells","volume":"33","author":"Khan","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2024.107652_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113956","article-title":"Curcumin: an epigenetic regulator and its application in cancer","volume":"156","author":"Ming","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2024.107652_b0345","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11010-012-1240-z","article-title":"Curcumin causes promoter hypomethylation and increased expression of fancf gene in siha cell line","volume":"365","author":"Parashar","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2024.107652_b0350","first-page":"1108","article-title":"Curcumin-induced promoter hypermethylation of the mammalian target of rapamycin gene in multiple myeloma cells","volume":"17","author":"Chen","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bioorg.2024.107652_b0355","doi-asserted-by":"crossref","first-page":"e0157866","DOI":"10.1371\/journal.pone.0157866","article-title":"Methylation landscape of human breast cancer cells in response to dietary compound resveratrol","volume":"11","author":"Castresana","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.107652_b0360","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/01635581.2014.868910","article-title":"Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue","volume":"66","author":"Qin","year":"2014","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.bioorg.2024.107652_b0365","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/cas.13029","article-title":"Peperomin E reactivates silenced tumor suppressor genes in lung cancer cells by inhibition of DNA methyltransferase","volume":"107","author":"Wang","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2024.107652_b0370","doi-asserted-by":"crossref","first-page":"52200","DOI":"10.1039\/C7RA09928B","article-title":"Peperomin E and its synthetic amino derivatives: potent agents targeting leukaemia stem cells","volume":"7","author":"Gao","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2024.107652_b0375","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1021\/np050457s","article-title":"Bioactive compounds from peperomia pellucida","volume":"69","author":"Xu","year":"2006","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2024.107652_b0380","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/np0600447","article-title":"Bioactive secolignans from peperomia dindygulensis","volume":"69","author":"Wu","year":"2006","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2024.107652_b0385","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/molecules24081472","article-title":"The Anti-Proliferation, Cycle arrest and apoptotic inducing activity of peperomin E on prostate cancer PC-3 cell line","volume":"24","author":"Li","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107652_b0390","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1159\/000495096","article-title":"Peperomin E induces promoter hypomethylation of metastatic-suppressor genes and attenuates metastasis in poorly differentiated gastric cancer","volume":"50","author":"Wanga","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bioorg.2024.107652_b0395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2017.09.004","article-title":"Genistein: its role in metabolic diseases and cancer","volume":"119","author":"Mukund","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bioorg.2024.107652_b0400","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1871520617666170918142114","article-title":"Genistein induces alterations of epigenetic modulatory signatures in human cervical cancer cells","volume":"18","author":"Sundaram","year":"2018","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0405","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/gcc.22154","article-title":"Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells","volume":"53","author":"Xie","year":"2014","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bioorg.2024.107652_b0410","unstructured":"Z.G. Wang, H. Chen, Genistein increases gene expression by demethylation of promoter in colon cancer cell line SW1116, Anticancer Res, 30 (2010) 4537-4545."},{"key":"10.1016\/j.bioorg.2024.107652_b0415","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fct.2015.05.001","article-title":"Quercetin protects mouse liver against nickel-induced DNA methylation and inflammation associated with the Nrf2\/HO-1 and p38\/STAT1\/NF-\u03baB pathway","volume":"82","author":"Liu","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2024.107652_b0420","doi-asserted-by":"crossref","first-page":"18357","DOI":"10.1002\/jcb.29147","article-title":"Quercetin modifies 5\u2032CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells","volume":"120","author":"Kedhari Sundaram","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2024.107652_b0425","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000166383","article-title":"Quercetin is able to demethylate the p16INK4a gene promoter","volume":"55","author":"Tan","year":"2009","journal-title":"Chemotherapy"},{"key":"10.1016\/j.bioorg.2024.107652_b0430","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3390\/biom7010003","article-title":"DNA methylation targeting: the DNMT\/HMT crosstalk challenge","volume":"7","author":"Castillo-Aguilera","year":"2017","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2024.107652_b0435","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4161\/epi.1.1.2358","article-title":"DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells","volume":"1","author":"Rivenbark","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.bioorg.2024.107652_b0440","doi-asserted-by":"crossref","first-page":"23858","DOI":"10.1074\/jbc.M113.480517","article-title":"Laccaic acid A Is a direct, DNA-competitive inhibitor of DNA methyltransferase 1","volume":"288","author":"Fagan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0445","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jsb.2011.07.015","article-title":"Molecular dynamics simulations of human DNA methyltransferase 3B with selective inhibitor nanaomycin A","volume":"176","author":"Caulfield","year":"2011","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bioorg.2024.107652_b0450","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1158\/1535-7163.MCT-10-0609","article-title":"Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells","volume":"9","author":"Kuck","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2024.107652_b0455","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/scd.2017.0251","article-title":"Nanaomycin A treatment promotes hepatoblast differentiation from human iPS cells","volume":"27","author":"Nakamae","year":"2018","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.bioorg.2024.107652_b0460","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2174\/1568009623666230522113645","article-title":"The DNMT3B inhibitor nanaomycin A as a neuroblastoma therapeutic agent","volume":"23","author":"Izumi","year":"2023","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bioorg.2024.107652_b0465","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3816\/CGC.2007.n.029","article-title":"Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy","volume":"5","author":"Amato","year":"2007","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.bioorg.2024.107652_b0470","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10637-006-5938-1","article-title":"Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: a national cancer institute of canada clinical trials group investigational new drug study","volume":"24","author":"Winquist","year":"2006","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.bioorg.2024.107652_b0475","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1158\/1078-0432.CCR-07-1320","article-title":"A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia","volume":"14","author":"Klisovic","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2024.107652_b0480","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/bjh.15870","article-title":"MIR29B mediates epigenetic mechanisms of HBG gene activation","volume":"186","author":"Starlard-Davenport","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bioorg.2024.107652_b0485","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/1477-3163.115720","article-title":"Restoration of the methylation status of hypermethylated gene promoters by microRNA-29b in human breast cancer: a novel epigenetic therapeutic approach","volume":"12","author":"Starlard-Davenport","year":"2013","journal-title":"J Carcinog"},{"key":"10.1016\/j.bioorg.2024.107652_b0490","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1021\/jm500843d","article-title":"Targeting DNA methylation with small molecules: what's next","volume":"58","author":"Erdmann","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107652_b0495","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1358\/dof.2013.38.8.1980499","article-title":"SGI-110: DNA methyltransferase inhibitor oncolytic","volume":"38","author":"Griffiths","year":"2013","journal-title":"Drugs Future"},{"key":"10.1016\/j.bioorg.2024.107652_b0500","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1093\/nar\/25.14.2773","article-title":"DNA containing 4'-thio-2'-deoxycytidine inhibits methylation by HhaI methyltransferase","volume":"25","author":"Kumar","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2024.107652_b0505","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1195380","article-title":"Structure of DNMT1-DNA Complex Reveals a Role for Autoinhibition in Maintenance DNA Methylation","volume":"331","author":"Song","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2024.107652_b0510","doi-asserted-by":"crossref","first-page":"15791","DOI":"10.1039\/D2CP02031A","article-title":"Structural view on the role of the TRD loop in regulating DNMT3A activity: a molecular dynamics study","volume":"24","author":"Zhao","year":"2022","journal-title":"PCCP"},{"key":"10.1016\/j.bioorg.2024.107652_b0515","first-page":"12476","article-title":"Structural basis for the allosteric regulation and dynamic assembly of DNMT3B, bioRxiv","volume":"51","author":"Lu","year":"2023","journal-title":"Biochem."},{"key":"10.1016\/j.bioorg.2024.107652_b0520","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nature05987","article-title":"DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA","volume":"448","author":"Ooi","year":"2007","journal-title":"Nature"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824005571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824005571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:46:11Z","timestamp":1781743571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824005571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":104,"alternative-id":["S0045206824005571"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107652","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting DNA methyltransferases for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107652"}}